S-3 GROUP

Lobbying for WALGREEN COMPANY · Pharmacy-led, health and wellbeing retail company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Health Issues

Issues related to pharmacy, pharmacist provider status, and Medicare reimbursement

Medicare/Medicaid

Issues related to the provider status of pharmacists under Medicare Part B

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.